Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc. financial statements

Acura Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2021

RevenueUSD 1.56MEODHD
Net income−USD 879KEODHD
Cash and equivalentsUSD 65KEODHD

Acura Pharmaceuticals, Inc. financials on 6ix · Acura Pharmaceuticals, Inc. on 6ix